Brief: Teva And Royalty Pharma Collaborate To Further Accelerate Olanzapine Lai Program
13/11/2023 14:37
Nov 13 (Reuters) - Royalty Pharma PLC RPRX.O :
* TEVA AND ROYALTY PHARMA COLLABORATE TO FURTHER ACCELERATE
OLANZAPINE LAI PROGRAM
Source text for Eikon: ID:nBw3LMV8Pa
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)